Notification close image
No new Notification messages
card image
Seshaasai Technologies Ltd IPO
Apply for the Seshaasai Technologies Ltd IPO through UPI in Just minutes
delete image
card image
Start your SIP with just ₹100
Choose from 4,000+ Mutual Funds on Bajaj Broking
delete image
card image
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
delete image
card image
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
delete image
card image
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
delete image

0

524790

EVERESTO

img img img img
No Data Available

EVEREST ORGANICS LTD. Share Price Update

As of the latest trading session, EVEREST ORGANICS LTD. share price is currently at ₹ 530, which is up by ₹ 30.00 from its previous closing. Today, the stock has fluctuated between ₹ 493.00 and ₹ 536.40. Over the past year, EVEREST ORGANICS LTD. has achieved a return of 66.11 %. In the last month alone, the return has been 18.20 %. Read More...

Investment Returns

Over 1 Month [-]% Over 3 Months [-]% Over 6 Months [-]% Over 1 Year [-]%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

EVEREST ORGANICS LTD. fundamentals


  • Market cap (Cr)

    [-]

  • P/E Ratio (TTM)

    [-]

  • Beta

    [-]

  • Book Value / share

    [-]

  • Return on equity

    [-]%

  • EPS (TTM)

    [-]

  • Dividend yield

    [-]%

  • Net profit/quarter (Cr)

    [-]

info icon alternate text
  • Market cap (Cr)

    514.70

  • P/E Ratio (TTM)

    73.42

  • Beta

    0.28

  • Book Value / share

    74.66

  • Return on equity

    -2.23%

  • EPS (TTM)

    6.81

  • Dividend yield

    [-]%

  • Net profit/quarter (Cr)

    1.16

info icon alternate text

EVEREST ORGANICS LTD. Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars SEP 2025 (Values in Cr)
Revenue 51.00
Operating Expense 48.62
Net Profit 1.16
Net Profit Margin (%) 2.27
Earnings Per Share (EPS) 1.19
EBITDA 5.42
Effective Tax Rate (%) 56.92
Particulars JUN 2025 (Values in Cr)
Revenue 53.81
Operating Expense 52.20
Net Profit 1.41
Net Profit Margin (%) 2.62
Earnings Per Share (EPS) 1.45
EBITDA 4.99
Effective Tax Rate (%) 35.18
Particulars MAR 2025 (Values in Cr)
Revenue 40.93
Operating Expense 40.21
Net Profit 2.91
Net Profit Margin (%) 7.10
Earnings Per Share (EPS) 3.00
EBITDA 3.65
Effective Tax Rate (%) -206.31
Particulars DEC 2024 (Values in Cr)
Revenue 42.05
Operating Expense 40.90
Net Profit 1.14
Net Profit Margin (%) 2.71
Earnings Per Share (EPS) 1.42
EBITDA 4.02
Effective Tax Rate (%) 0.86
Particulars SEP 2024 (Values in Cr)
Revenue 44.05
Operating Expense 43.44
Net Profit 0.74
Net Profit Margin (%) 1.67
Earnings Per Share (EPS) 0.93
EBITDA 3.57
Effective Tax Rate (%) 1.33
Particulars MAR 2025 (Values in Cr)
Revenue 159.48
Operating Expense 163.41
Net Profit -1.29
Net Profit Margin (%) -0.80
Earnings Per Share (EPS) -1.33
EBITDA 7.91
Effective Tax Rate (%) 60.18
Particulars MAR 2024 (Values in Cr)
Revenue 197.24
Operating Expense 197.52
Net Profit 0.14
Net Profit Margin (%) 0.07
Earnings Per Share (EPS) 0.17
EBITDA 11.87
Effective Tax Rate (%) 77.04
Particulars MAR 2023 (Values in Cr)
Revenue 183.05
Operating Expense 189.90
Net Profit -0.18
Net Profit Margin (%) -0.09
Earnings Per Share (EPS) -0.23
EBITDA 7.86
Effective Tax Rate (%) 300.00
Particulars MAR 2022 (Values in Cr)
Revenue 200.05
Operating Expense 200.51
Net Profit 1.14
Net Profit Margin (%) 0.56
Earnings Per Share (EPS) 1.43
EBITDA 8.64
Effective Tax Rate (%) 34.48
Particulars MAR 2021 (Values in Cr)
Revenue 181.57
Operating Expense 165.35
Net Profit 13.72
Net Profit Margin (%) 7.55
Earnings Per Share (EPS) 17.14
EBITDA 23.90
Effective Tax Rate (%) 20.61
Particulars MAR 2025 (Values in Cr)
Book Value / Share 71.00
ROE % -2.23
ROCE % 1.72
Total Debt to Total Equity 0.91
EBITDA Margin 4.34
Particulars MAR 2024 (Values in Cr)
Book Value / Share 57.30
ROE % 0.30
ROCE % 5.94
Total Debt to Total Equity 1.18
EBITDA Margin 5.25
Particulars MAR 2023 (Values in Cr)
Book Value / Share 57.77
ROE % -0.17
ROCE % 3.55
Total Debt to Total Equity 0.97
EBITDA Margin 3.75
Particulars MAR 2022 (Values in Cr)
Book Value / Share 58.50
ROE % 2.44
ROCE % 6.02
Total Debt to Total Equity 0.66
EBITDA Margin 3.75
Particulars MAR 2021 (Values in Cr)
Book Value / Share 58.22
ROE % 33.97
ROCE % 32.07
Total Debt to Total Equity 0.51
EBITDA Margin 11.53
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 6.63
Total Assets 224.48
Total Liabilities 224.48
Total Equity 69.94
Share Outstanding 9710526
Price to Book Ratio 3.55
Return on Assets (%) -0.57
Return on Capital (%) -1.1
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.82
Total Assets 226.62
Total Liabilities 226.62
Total Equity 45.83
Share Outstanding 8000000
Price to Book Ratio 2.00
Return on Assets (%) 0.06
Return on Capital (%) 0.13
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.82
Total Assets 201.84
Total Liabilities 201.84
Total Equity 46.21
Share Outstanding 8000000
Price to Book Ratio 1.65
Return on Assets (%) -0.09
Return on Capital (%) -0.19
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.65
Total Assets 177.99
Total Liabilities 177.99
Total Equity 46.79
Share Outstanding 8000000
Price to Book Ratio 2.97
Return on Assets (%) 0.64
Return on Capital (%) 1.34
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 1.66
Total Assets 135.37
Total Liabilities 135.37
Total Equity 46.57
Share Outstanding 8000000
Price to Book Ratio 3.95
Return on Assets (%) 10.13
Return on Capital (%) 19.74
Particulars MAR 2025 (Values in Cr)
Net Income -3.24
Cash from Operations -5.49
Cash from Investing -5.16
Cash from Financing 16.36
Net change in Cash 5.81
Free Cash Flow -0.06
Particulars MAR 2024 (Values in Cr)
Net Income 0.61
Cash from Operations 16.07
Cash from Investing -12.99
Cash from Financing -3.09
Net change in Cash 0.00
Free Cash Flow 29.16
Particulars MAR 2023 (Values in Cr)
Net Income -0.18
Cash from Operations 18.41
Cash from Investing -15.59
Cash from Financing -2.64
Net change in Cash 0.17
Free Cash Flow 31.94
Particulars MAR 2022 (Values in Cr)
Net Income 1.14
Cash from Operations 13.73
Cash from Investing -16.81
Cash from Financing 2.06
Net change in Cash -1.01
Free Cash Flow 30.89
Particulars MAR 2021 (Values in Cr)
Net Income 13.71
Cash from Operations 13.53
Cash from Investing -11.81
Cash from Financing -2.05
Net change in Cash -0.33
Free Cash Flow 20.38
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 28.58 14.01 1.48 219.02 25.97 / 59.99
BLISS GVS PHARMA LTD 163.50 15.78 1.52 1729.65 105.05 / 190.65
CIPLA LTD 1510.90 22.43 3.70 122046.15 1310.05 / 1672.20
FERMENTA BIOTECH LIMITED 348.00 9.14 2.61 1024.20 219.00 / 449.00
GLAXOSMITHKLINE PHARMA LT 2470.95 43.91 24.51 41859.38 1924.30 / 3515.95
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 28.89 23.49 4.02 221.39 25.97 / 59.99
AMRUTAJAN HEALTH LTD 667.10 34.02 5.63 1928.63 548.05 / 829.00
ASTRAZENECA PHARMA IND LT 8777.40 94.92 27.46 21943.50 6501.60 / 10653.05
BLISS GVS PHARMA LTD 162.00 21.86 1.55 1713.78 105.05 / 190.65

EVEREST ORGANICS LTD. shareholding pattern

Holding

40.33%
59.64%
0.02%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

EVEREST ORGANICS LTD. Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
530.00 6.00 redarrow
red-green-graph indicator
16 Bearish
0 Bullish
  • 5 Days 492.50
  • 26 Days 462.90
  • 10 Days 482.80
  • 50 Days 443.80
  • 12 Days 479.80
  • 100 Days 417.70
  • 20 Days 469.40
  • 200 Days 375.00
497.03 PIVOT

First Support

485.07

First Resistance

511.97

Second Support

470.13

Second Resistance

523.93

Third Support

458.17

Third Resistance

538.87

RSI

60.87

ADX

18.06

MACD

16.84

Williams % R

-18.11

Commodity Channel Index (CCI)

121.69

Date

2026-01-01

Week

3660.00

Same Day

1844.00

Month

2592.00

1 Year

0.28

3 Year

0.27

Over 1 Month

18.20%

down

Over 1 Year

66.11%

down

Over 3 Months

23.18%

down

Over 3 Years

59.68%

down

Over 6 Months

39.62%

down

Over 5 Years

12.06%

down

EVEREST ORGANICS LTD. Corporate Actions

Dividend date Dividend amount Dividend type Record date Instrument type
15 Sep 2022 0.5 Final 17 Sep 2022 Equity shares
08 Sep 2021 1.0 Final 11 Sep 2021 Equity shares
17 Feb 2021 0.5 Interim 18 Feb 2021 Equity shares
01 Sep 2020 1.0 Final 03 Sep 2020 Equity shares
03 Sep 2019 1.0 Final 05 Sep 2019 Equity shares

EVEREST ORGANICS LTD. Share Price

Everest Organics Limited was incorporated at Hyderabad in February, 1993. It was promoted by S K Srihari Raju and S K. Chittiramabhadra Raju. The Company is engaged in manufacturing of Active Pharmaceutical Ingredients and their intermediaries. The Company commenced its commercial operations in the year 1993. It set up a plant at Aroor, Andhra Pradesh to manufacture bulk drugs and formulations. It came out with a public issue in Jan.'95 to part-finance the project.

Commercial production of ciprofloxacin and omerprazole commenced in Feb.'96. The company preferred to manufacture para hydroxy phynyl glycin (PHPG), but due to market conditions, it decided to drop manufacturing of PHPG and has decided to enhance the capacity of ciprofloxacin from 30 tpa to 120 tpa and also to manufacture enrofloxacin/naproxen. It introduced one more new product by name Esomeprazole Magnesium by creating additional facility by making investment in plant & machinery in 2007-08.

In 2024-25, the Company increased its installed capacity of Benzimidazole by 60 tpa there by taking its capacity to 120 tpa. The installed capacity of Omeprazole Op Sulphide has been increased from 15 TPA to 30 TPA in FY 2025.

Parent organization Indian Private
NSE symbol [-]
Founded 1993
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Everest Organics Ltd?

Answer Field

Everest Organics Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 530.00 as on Jan 02 2026 02:35 PM.

What is the Market Cap of Everest Organics Ltd Share?

Answer Field

The market cap of Everest Organics Ltd for NSE ₹ 0.00 & for BSE ₹ 514.70 as on Jan 02 2026 02:35 PM.

What is the 52 Week High and Low of Everest Organics Ltd?

Answer Field

The 52 Week High and Low of Everest Organics Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 536.40 and ₹ 210.95.

What is 1 year return for Everest Organics Ltd?

Answer Field

The 1 year returns on the stock has been 66.11%.

What is the P/E Ratio of Everest Organics Ltd Share?

Answer Field

As on Jan 02 2026 02:35 PM the price-to-earnings (PE) ratio for Everest Organics Ltd share is 73.42.

What is the PB ratio of Everest Organics Ltd Share?

Answer Field

As on Jan 02 2026 02:35 PM, the price-to-book (PB) ratio for Everest Organics Ltd share is 74.66.

How to Buy Everest Organics Ltd Share?

Answer Field

You can trade in Everest Organics Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Everest Organics Ltd Share on Bajaj Broking App?

Answer Field

To buy Everest Organics Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Everest Organics Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59